Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016

Abstract Introduction Financial relationships between pharmaceutical companies and dementia clinical practice guideline (CPG) authors are possibly biasing the recommendations in Japan. This study aimed to reveal characteristics and distribution of pharmaceutical payments made to Japanese dementia CP...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Financial conflicts of interest
Dementia
Clinical practice guidelines
Japan
Pharmaceutical payments
Online Access:https://doi.org/10.1016/j.trci.2019.05.003
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1016/j.trci.2019.05.003

Similar Items